Pediatrix Medical Group (NYSE: MD) insider transactions

In the twelve months to 10 November 2026, executives and directors of Pediatrix Medical Group reported 3 open-market sales of 69,506 shares ($1.6m) and 0 open-market purchases, by 3 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Pediatrix Medical Group shares reported on Form 4
Date	Insider	Role	Transaction	Shares	Price	Held after	Filing
10 September 2026	Linynsky Laura A	Director	Returned to the company	−6,000	$26.82	33,900	Form 4
14 August 2026	Young Sylvia Jean	Director	Returned to the company	−18,500	$26.62	29,786	Form 4
12 August 2026	Sansone Guy P	Director	Grant or award	+472	$26.50	87,416	Form 4
12 August 2026	Young Sylvia Jean	Director	Grant or award	+472	$26.50	48,286	Form 4
12 August 2026	Rucker Michael A.	Director	Grant or award	+472	$26.50	66,769	Form 4
12 August 2026	Linynsky Laura A	Director	Grant or award	+472	$26.50	39,900	Form 4
12 August 2026	Newman Kurt Douglas	Director	Grant or award	+472	$26.50	17,405	Form 4
12 August 2026	Starcher John M. Jr.	Director	Grant or award	+472	$26.50	73,732	Form 4
12 August 2026	Weis Shirley A	Director	Grant or award	+472	$26.50	19,095	Form 4
12 August 2026	McEachin Thomas	Director	Grant or award	+472	$26.50	7,668	Form 4
22 June 2026	Haddock David	EVP, GC & Corp Sec	Grant or award	+20,036	—	20,036	Form 4
9 June 2026	Moore Mary Ann E	EVP, GC, Chief Admin Off & Sec	Gift	−18,407	—	78,059	Form 4
9 June 2026	Moore Mary Ann E	EVP, GC, Chief Admin Off & Sec	Gift	+18,407	—	111,831	Form 4
2 June 2026	Ordan Mark S	Chief Executive Officer	Returned to the company	−97,174	—	313,710	Form 4
2 June 2026	Ordan Mark S	Chief Executive Officer	Grant or award	+97,174	—	410,884	Form 4
1 June 2026	Moore Mary Ann E	EVP, GC, Chief Admin Off & Sec	Shares withheld for tax	−11,944	$21.54	96,466	Form 4
1 June 2026	Neeb Don Gregory	EVP, Chief Invest & Strategy	Grant or award	+63,888	—	145,234	Form 4
1 June 2026	Neeb Don Gregory	EVP, Chief Invest & Strategy	Shares withheld for tax	−8,003	$21.54	137,231	Form 4
1 June 2026	Ordan Mark S	Chief Executive Officer	Grant or award	+127,198	—	430,003	Form 4
1 June 2026	Ordan Mark S	Chief Executive Officer	Shares withheld for tax	−19,119	$21.54	410,884	Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Pediatrix Medical Group page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.